BISOPROLOL FUMARATE

Post-LOE

bisoprolol fumarate

ANDAORALTABLET
Approved
Nov 2000
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

CLINICAL PHARMACOLOGY Bisoprolol fumarate is a beta 1 -selective (cardioselective) adrenoceptor blocking agent without significant membrane stabilizing activity or intrinsic sympathomimetic activity in its therapeutic dosage range. Cardioselectivity is not absolute, however, and at higher doses (≥…